ConductScience.org, home

Gene · 7399

NIH grants1,190

NIH grants whose papers are about the gene, through NIH's grant-paper links.

GrantTitleUSH2A papersNewest fiscal year
P30EY007003University of Michigan Vision Research Center22025
P30EY016665Core Grant for Vision Research22025
P51OD011107California National Primate Research Center22025
R01DC000188Cochlear synaptopathy in noise-induced and age-related hearing loss: mechanisms and treatments22025
R01DC003594Identification of Autosomal Recessive Nonsyndromic Hearing Impairment Genes22025
R01DC009645A Collaborative Search for New Genes for Non-Syndromic Deafness22025
R01DC017147Taperin-based macromolecular complex at the base of stereocilia22025
R01DC022239Development of human inner ear organoid platforms for human auditory/vestibular disorders22025
R01EY026559CLARIN 1 RETINAL FUNCTION AND THERAPEUTIC IMPLICATIONS FOR USH322025
R01EY033103Developing photoreceptor repair for macular degeneration therapy.22025
R01EY034671Non-viral gene delivery platforms for the treatment of Usher Syndrome Type 2A.22025
R25DC020726Miami Otolaryngology Surgeon-Scientist Training Program (MOSSTP)22025
R35GM139453Structural Studies of Macromolecular Assemblies Using Cryo-EM22025
T15LM007093NLM Research Training Program in Biomedical Informatics and Data Science for Predoctoral and Postdoctoral Fellows22025
T32AI007647Training Program in Mechanisms of Virus-Host Interactions22025
T32EY014537Research Training Program in Vision Science22025
T32EY026590Translational Vision Research Training at UCSD22025
T32GM008638Medical Genetics Research Training Grant22025
ZIAAI001028Structure and Function of Viral Immunoevasins22025
ZIADC000048Functional Studies of "Deafness Genes" Essential for Hearing22025

Source NIH's project filesgene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/7399/grants?page=3